$193.60
▼ -0.0% Today
as of Sep 4, 16:46 ET
Last 30 days
Recent Press Releases & News
Belite Bio Shares Rise After Canaccord Initiates Coverage With Buy Rating
Belite Bio's Tinlarebant Revenue Estimates Have Multiple Drivers of Upside, Mizuho Says
Canaccord Genuity Initiates Belite Bio at Buy With $303 Price Target
Overview
52-week range
$65
$200
95% of range
Avg surprise (last 3)
+4.0%
Avg reaction (last 2)
+0.4%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Wed May 20, 2026 | Mar/2026 | $-0.34 | $-0.60 | +43.3% | +24.4% | +2.6% | earnings |
| Mon Aug 11, 2025 | Jun/2025 | $-0.50 | $-0.47 | -6.4% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.45 | $-0.36 | -25.0% | — | -1.8% | earnings |
Implied volatility — last 90 days
No IV snapshots yet for BLTE.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.